Literature DB >> 19427630

Intrahepatic cholangiocarcinoma: analysis of 44 consecutive resected cases including 5 cases with repeat resections.

Akio Saiura1, Junji Yamamoto, Norihiro Kokudo, Rintaro Koga, Makoto Seki, Naoki Hiki, Kazuhiko Yamada, Takeshi Natori, Toshiharu Yamaguchi.   

Abstract

BACKGROUND: Prognosis after resection for intrahepatic cholangiocarcinoma (ICC) remains unsatisfactory. There remains no effective therapy after recurrent ICC.
OBJECTIVE: The current study sought to evaluate risk factors associated with recurrent ICC and possible therapies after resection.
METHOD: A review of data from patients who underwent potentially curative resection for ICC was performed.
RESULTS: A total of 44 potentially curative resections were performed from 1995 to 2008. Mortality was 0% and morbidity was 35%. The 5-year overall and recurrence-free survival rates were 43% and 39%, respectively. Multivariate analysis identified the presence of multiple nodules and poor histologic grade as independent negative prognostic factors for overall and recurrent-free survival. Postoperative recurrence occurred in 25 patients (57%). Solitary recurrence occurred in 5 patients (liver, n = 4; lung, n = 1), all of who had undergone surgical resection. Three of the 5 patients survived for more than 5 years after 2 resections.
CONCLUSION: Prognosis after curative resection of solitary ICC appears favorable. In selected patients with sequential single hepatic or pulmonary recurrence, repeat resection may prolong survival. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19427630     DOI: 10.1016/j.amjsurg.2008.12.035

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  22 in total

1.  Survival Benefits of Surgical Resection in Patients with Recurrent Biliary Tract Carcinoma.

Authors:  Hiroaki Motoyama; Akira Kobayashi; Takahide Yokoyama; Akira Shimizu; Noriyuki Kitagawa; Tsuyoshi Notake; Kentaro Fukushima; Hitoshi Masuo; Takahiro Yoshizawa; Shin-Ichi Miyagawa
Journal:  World J Surg       Date:  2017-11       Impact factor: 3.352

2.  Locoregional recurrence after curative intent resection for intrahepatic cholangiocarcinoma: implications for adjuvant radiotherapy.

Authors:  S Song; K Kim; E K Chie; S Kim; H J Park; N J Yi; K-S Suh; S W Ha
Journal:  Clin Transl Oncol       Date:  2015-06-04       Impact factor: 3.405

3.  Adjuvant transcatheter arterial chemoembolization for intrahepatic cholangiocarcinoma after curative surgery: retrospective control study.

Authors:  W F Shen; W Zhong; Q Liu; C J Sui; Y Q Huang; J M Yang
Journal:  World J Surg       Date:  2011-09       Impact factor: 3.352

Review 4.  Surgical treatment for intrahepatic cholangiocarcinoma.

Authors:  Takahiro Uenishi; Takatsugu Yamamoto; Shigekazu Takemura; Shoji Kubo
Journal:  Clin J Gastroenterol       Date:  2014-02-15

Review 5.  The value of systematic lymph node dissection for intrahepatic cholangiocarcinoma from the viewpoint of liver lymphatics.

Authors:  Yuji Morine; Mitsuo Shimada
Journal:  J Gastroenterol       Date:  2015-04-02       Impact factor: 7.527

Review 6.  Photodynamic therapy for unresectable cholangiocarcinoma.

Authors:  Yutaka Tomizawa; Jianmin Tian
Journal:  Dig Dis Sci       Date:  2011-11-06       Impact factor: 3.199

Review 7.  Multimodality Management of Localized Biliary Cancer.

Authors:  Nadia Ashai; Preethi Prasad; Lakshmi Rajdev
Journal:  Curr Treat Options Oncol       Date:  2019-05-29

8.  Prediction of the histopathologic findings of intrahepatic cholangiocarcinoma: qualitative and quantitative assessment of diffusion-weighted imaging.

Authors:  Sara Lewis; Cecilia Besa; Mathilde Wagner; Kartik Jhaveri; Shingo Kihira; Hongfa Zhu; Nima Sadoughi; Sandra Fischer; Amogh Srivastava; Eric Yee; Koenraad Mortele; James Babb; Swan Thung; Bachir Taouli
Journal:  Eur Radiol       Date:  2017-12-12       Impact factor: 5.315

9.  Prognostic factors in resectable cholangiocarcinoma patients: Carcinoembryonic antigen, lymph node, surgical margin and chemotherapy.

Authors:  Kosin Wirasorn; Thundon Ngamprasertchai; Jarin Chindaprasirt; Aumkhae Sookprasert; Narong Khantikaew; Ake Pakkhem; Piti Ungarereevittaya
Journal:  World J Gastrointest Oncol       Date:  2013-04-15

10.  Radiofrequency ablation for postoperative recurrences of intrahepatic cholangiocarcinoma.

Authors:  Ying Fu; Wei Yang; Wei Wu; Kun Yan; Bao-Cai Xing; Min-Hua Chen
Journal:  Chin J Cancer Res       Date:  2011-12       Impact factor: 5.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.